---
company: Grown Rogue International Inc.
ticker: GRUSF
form: 8-K
filed: 2026-05-12
accession: 0001279569-26-000430
source: https://www.sec.gov/Archives/edgar/data/1463000/000127956926000430/
---

# Grown Rogue International (GRUSF) earnings release, May 12, 2026

Grown Rogue International Inc. (GRUSF) · Form 8-K, Item 2.02 · Filed 2026-05-12 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1463000/000127956926000430/)

Grown Rogue Reports First

Quarter 2026 Results

Continued Solid New Jersey

Performance, Yield Improvements, Product Expansion, and New Market Progress Support Growth Plans & Upwardly Revised Revenue Guidance

MEDFORD, Ore., May 12, 2026 /CNW/ - Grown Rogue International

Inc. ("Grown Rogue," "we," "us," "our," or the "Company") (CSE: GRIN | OTC: GRUSF), a flower-forward cannabis company combining craft values with disciplined execution, today reported its unaudited financial results for the three months ended March 31, 2026. All currency is in U.S. dollars unless otherwise noted.

Results are presented in accordance with U.S. generally accepted accounting principles ("GAAP") and include consolidation of the Company's New Jersey operations, ABCO Garden State,

LLC ("ABCO"), within the Company's financial statements. Comparative periods have been recast, where applicable, in accordance with GAAP.

Highlights:

First Quarter 2026 Update

First quarter 2026 results reflected continued progress against the Company's growth plan, including increased contribution from New Jersey, continued operating discipline in Oregon and Michigan, and ongoing work to broaden the Company's product offering and market footprint. The quarter was also the first full quarter following the Company's transition to U.S. GAAP reporting and consolidation of ABCO, creating a clearer baseline for evaluating performance as expansion projects in New Jersey, Illinois, and Minnesota advance.

In New Jersey, demand and sell-through remained strong across packaged, branded products which represented 97% of New Jersey revenue in the quarter, Management believes quality, consistency, and affordability are the cornerstones of strong consumer loyalty across markets. The Company continued executing its Phase II expansion, which is expected to increase total New Jersey flowering canopy to approximately 16,000 square feet when complete later this year. As this capacity comes online, management anticipates short-term, modest reductions in the percentage of packaged, branded products sold.

In Oregon and Michigan, the Company continued to focus on controllable factors, including cost per pound, yields, harvest quality, product consistency, and targeted infrastructure improvements.

Oregon revenue increased approximately 4% year-over-year, while Michigan revenue increased approximately 10% year-over-year, primarily due to the pass-through of Michigan's new wholesale excise tax which was implemented on January 1, 2026. Excluding that impact, which was absorbed in price, Michigan revenue declined approximately 4% year-over-year. Both markets continued to experience pricing pressure, which impacted profitability in the quarter. In Michigan, yield performance continued to improve, and the Company is beginning to apply similar infrastructure improvements in Oregon with the objective of moving flower yield performance from recent levels in the 70 g/sf range toward the 80 g/sf range.

The new vape category also reflects a product expansion strategy focused on staying true to our flower-forward ethos with disciplined SKU expansion and fuller utilization of the Company's efficient production capabilities. In Oregon, the Company is using its cultivation capabilities to convert select biomass streams that historically carry lower margins, into higher value branded vape products. Management views this as a capital-efficient way to extend the Grown Rogue brand into new consumption formats while preserving the genetics, flavor, and quality standards associated with its flower.

The Company also advanced its new-market pipeline, including construction activity in Minnesota and progressing towards restarting the recently inhabited turn-key Illinois facility. These projects are expected to be important contributors to the Company's 2027 financial performance, subject to the assumptions and risks described in this release.

Management Commentary

"The first quarter was a continuation of the plan we laid out earlier this year: keep building in markets where we believe quality flower and disciplined execution can earn attractive returns, while staying sharp in mature markets that require strong cost control and operational excellence," said Obie Strickler,

Chief Executive Officer. "New Jersey continues to validate our thesis, with consistent demand for our packaged, branded products and meaningful expansion work underway. At the same time, we are seeing evidence that the technology upgrade work done in Michigan is translating into stronger yield performance, and we have begun upgrading our facilities in Oregon. Mature markets keep us focused on the fundamentals that have always mattered most to Grown Rogue: genetics, passion, quality, consistency, and efficient production.

In addition to the markets themselves being cash flow contributors, they provide a best-practices laboratory for us to adapt practices across markets as the teams and facilities are ready."

Mr. Strickler continued, "Our priorities for

2026 remain clear. We are focused on completing Phase II in New Jersey, advancing our Minnesota buildout, preparing Illinois for operations, and continuing to broaden our product offering without losing the discipline that defines our approach. The new vape category is an example of that approach: using more of the plant and our in-house capabilities to create higher-value branded products in formats consumers are already choosing, while staying true to being flower forward with the genetics, flavor and flower integrity that define Grown Rogue. Assuming we navigate the regulatory timelines and inherent execution risks, we believe these initiatives can position Grown Rogue to enter 2027 with a more diversified operating base, a larger share of revenue from newer markets, and a stronger platform for sustainable profit growth."

Josh Rosen, Chief Strategy Officer, added, "Our... (truncated)market. It is based on disciplined underwriting and building where we believe our capabilities matter most. Minnesota is a new-build opportunity in a market we believe can support attractive economics, while

Illinois is a lower-capital-intensity, 'fixer-upper' opportunity where operational discipline may unlock meaningful value. Across the portfolio, our focus remains on improving yields, quality, and consistency, while expanding wallet share with a targeted set of flower-forward products.

Andrew Marchington, Chief Financial Officer, commented,

"First quarter 2026 marks our first quarterly reporting period following the transition to U.S. GAAP reporting and the consolidation of ABCO within our financial statements. We remain focused on transparent reporting, working capital discipline, cost controls, and allocating capital to projects that we believe meet our return thresholds. As we move through 2026 into 2027, we expect investors will have a clearer view of the operating profile of the business and the contribution of our newer markets. Of note, as we've managed our transition to GAAP, we've also been working on the integration of our core operational data with our financial performance and we found that we had not properly eliminated all of our selling costs as we recalibrated our cost of production metrics in our Operating KPIs, thus leading to a restatement of that metric looking backward as well."

Selected First Quarter 2026 Financial Results (Unaudited)

Selected Quarterly Revenue by Segment (Unaudited)

Operating KPIs by Market

Guidance and Long-Term (3-5 Year) Growth Objectives

Management is reiterating the financial framework introduced in April 2026 to assist investors in evaluating the Company's growth strategy and capital allocation discipline. The guidance and long-term objectives set out below reflect current expectations, assumptions, and management objectives as of the date of this release and are subject to the forward-looking statements disclosure included herein.

Growth Framework

Long-term (3-5 year) Targets and Guidance

2026 Guidance Assumptions:

2026 guidance excludes the start-up (pre-revenue) expenses in both Illinois and Minnesota of approximately $1.5 million to $2.0 million each. Illinois is expected to begin contributing revenue in Q4 2026 with approximately 5,000 square feet of flowering canopy initially online. Minnesota is expected to begin contributing revenue in the first quarter of 2027 with approximately 8,000 square feet of flowering canopy online. In New Jersey, the Company expects the current expansion to be substantially complete by Q4 2026, with ramp and sell-through reaching targeted levels by Q1 2027. As a result, the expansion is expected to contribute modestly to revenue and Adjusted EBITDA (non-GAAP) in 2026 and is more fully reflected in 2027 guidance. Overall, the Company anticipates consolidated gross margins of greater than 40% and corporate overhead expenses to increase by less than 10% in 2026.

2027 Guidance Assumptions:

2027 guidance assumes modest wholesale price normalization from 2026 levels in New Jersey and Illinois of approximately 10% and 5%, respectively. Minnesota is assumed to remain supply-constrained, supporting wholesale flower pricing above $2,500 per pound. In Oregon and Michigan, the guidance assumes no change in the current pricing environment, which management believes represents an appropriately conservative case for those markets. New Jersey assumes completion of the Phase II expansion in 2026, with 2027 reflecting a full year at expanded capacity. The Company currently plans to expand Illinois flowering canopy from 5,000 to 14,000 square feet and to expand Minnesota flowering canopy from 8,000 to approximately 16,000 square feet in mid-2027, utilizing existing capital and internally generated cash flow to fund the expansions.

Overall, the Company anticipates consolidated gross margins of greater than 42% and corporate overhead expenses to increase by less than

25% in 2027.

General Assumptions.

Guidance and long-term objectives exclude any potential changes in U.S. federal cannabis policy and do not assume M&A or additional distressed opportunities unless explicitly stated.

State-by-State Indoor Cultivation Flowering Capacity

(Bench Canopy)

On average, Grown Rogue anticipates producing approximately

800-900 lbs of flower annually per 1,000 square feet of flower canopy.

Conference Call and Webcast Information

Grown Rogue will host a conference call and webcast on Tuesday, May 12, 2026, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss its first quarter 2026 results and provide a corporate update

To further enhance investor disclosure, the Company will also post an updated Company Overview presentation to its website in advance of the call.

Conference Call Details

A telephone replay of the conference call will be available until May 19, 2026, by dialing (+1) 888 660 6345 and entering replay code 19264#. A transcript of the call will also be made available on Grown Rogue's Investor Relations website at https://www.grownrogue.com/investors.

For assistance, please contact: invest@grownrogue.com.

The contents of our investor relations website are not incorporated by reference into this press release or any report or document that

Grown Rogue files with the SEC or Canadian Securities Administrators ("CSA"), and any references to the websites are intended to be inactive textual references only.

About Grown Rogue

Grown Rogue International Inc. (CSE: GRIN | OTC: GRUSF) is a flower-forward cannabis company rooted in Oregon's Rogue Valley, a region known for its deep cannabis heritage and commitment to quality. With operations in Oregon, Michigan, and New Jersey - and expansion underway in Illinois and Minnesota - Grown Rogue specializes... (truncated) budtenders, and consumers alike. By blending craft values with disciplined execution, the Company has built a scalable, capital-efficient platform designed to thrive in competitive markets. The Company believes sustained excellence in cannabis flower production is the engine of the industry's supply chain - and its competitive advantage. For more information about Grown Rogue, please visit www.grownrogue.com.

The contents of our website are not incorporated by reference into this press release or any report or document that Grown Rogue files with the SEC or CSA, and any references to the websites are intended to be inactive textual references only.

Consolidated Statements of Income (Loss) and Comprehensive

Income (Loss) (Unaudited)

For the three months ended March 31, 2026 and 2025

(US$ in millions)

Consolidated Balance Sheets (Unaudited)

As of March 31, 2026 and December 31, 2025

(US$ in millions)

Consolidated Statements of Cash Flow (Unaudited)

For the three months ended March 31, 2026 and 2025

(US$ in millions)

Adjusted EBITDA Reconciliation Table (Unaudited)

Three months ended March 31, 2026

(US$ in millions)

Preliminary Segmented Adjusted EBITDA (Unaudited)

- Three months ended March 31, 2026

(US$ in millions)

Quarterly Adjusted EBITDA (Unaudited) - Trailing

5 quarters

(US$ in millions)

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release contains "forward looking information" and "forward-looking statements" within the meaning of applicable securities laws, including, without limitation, statements regarding: the Company's financial guidance and long-term targets; anticipated timing, capacity, ramp and revenue contributions in Illinois, Minnesota and New Jersey; future capital allocation; growth opportunities; pricing assumptions; working capital requirements; and the expected benefits of the Company's transition from IFRS to GAAP and consolidation of ABCO. Forward-looking statements are often identified by words such as "may," "would," "could,"

"should," "will," "intend," "plan," "anticipate," "believe," "estimate,"

"expect," "target," "guidance," or similar expressions.

Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, forward-looking statements are based on management's current expectations, estimates, assumptions and projections as of the date of this release, including, without limitation, assumptions regarding market conditions, wholesale pricing, demand, construction timelines, regulatory approvals, capital availability, operating performance, and the timing of new market launches and expansion projects. Although the Company believes these assumptions are reasonable, forward-looking statements are inherently subject to risks and uncertainties, and undue reliance should not be placed on such statements.

Actual results may differ materially from those expressed or implied by forward-looking statements as a result of a number of known and unknown risks and uncertainties, including, without limitation: changes in general economic, business and political conditions; access to debt or equity capital on acceptable terms; adverse changes in the public perception of cannabis; decreases in prevailing prices for cannabis and cannabis products in the markets in which the Company operates; regulatory developments and the timing or availability of required approvals; the pace and cost of construction, commissioning and ramp activities; and the other risks described in the Company's public disclosure documents filed on SEDAR+ and www.sec.gov.

The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned that future-oriented financial information and financial outlooks contained in this release are provided for the purpose of describing management's current expectations and may not be appropriate for other purposes. The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities; however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company's business is disclosed in the Company's public disclosure documents filed on SEDAR+ and www.sec.gov.

Non-GAAP Financial Measures

This press release contains certain non-GAAP financial measures. These measures are presented as supplemental information and should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP. Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are included in the financial schedules accompanying this release. Forward-looking non-GAAP guidance is provided on the basis described under "Guidance and Long-Term Growth Objectives."

SOURCE Grown Rogue International Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2026/12/c3762.html

%CIK: 0001463000

For further information:

General Inquiries and Investor Contact:

Obie Strickler, Chief Executive Officer, obie@grownrogue.com; Investor Relations: invest@grownrogue.com, (458) 226-2662

CO: Grown Rogue International Inc.

CNW 16:05e 12-MAY-26

## Financial statements

### Income Statement ((US$ in millions))

| | 2026 – $ | 2025 – $ |
|---|---:|---:|
| Revenue | Product sales | 9,155,658 | 7,150,183 |
| Revenue | Total revenue | 9,155,658 | 7,150,183 |
| Cost of goods sold | Cost of finished cannabis inventory sold | -5,198,024 | -3,786,436 |
| Cost of goods sold | Total cost of goods sold | -5,198,024 | -3,786,436 |
| Cost of goods sold | Gross profit | 3,957,634 | 3,363,747 |
| Operating expenses | Amortization (Notes 9, 10) | 91,162 | 104,984 |
| Operating expenses | General and administrative | 3,611,823 | 2,532,254 |
| Operating expenses | Share-based compensation (Note 16) | 154,994 | 1,435,910 |
| Operating expenses | Total operating expenses | 3,857,979 | 4,073,148 |
| Operating expenses | Income (loss) from operations | 99,655 | -709,401 |
| Other income (expense) | Interest and accretion expense (Note 11, 13) | -549,980 | -258,171 |
| Other income (expense) | 165,268 | 796,956 |
| Other income (expense) | Interest income (Note 8) | 42,187 | 35,937 |
| Other income (expense) | Unrealized gain on derivative liability (Note 13) | 66,377 | 2,864,373 |
| Other income (expense) | Realized loss on derivative liability (Note 13) |  | -29,288 |
| Other income (expense) | Unrealized gain (loss) on warrant asset (Note 6) | -2,191,084 | -1,172,492 |
| Other income (expense) | Unrealized gain on change in fair value of warrant liability (Note 13.3) | 770,714 |  |
| Other income (expense) | Loss on equity investment in associate (Note 7) | -99,657 | -153,734 |
| Other income (expense) | Total other income (expense), net | -1,796,175 | 2,083,581 |
| Other income (expense) | Income (loss) before income tax expense | -1,696,520 | 1,374,180 |
| Other income (expense) | Income tax expense (Note 18) | -516,871 | -631,310 |
| Other income (expense) | Net income (loss) | -2,213,391 | 742,870 |
| Other comprehensive income | Currency translation adjustment |  | 7,832 |
| Other comprehensive income | Total comprehensive income (loss) | -2,213,391 | 750,702 |
| Other comprehensive income | Basic income (loss) per share | 0 | 0 |
| Other comprehensive income | Basic weighted average number of subordinate voting common shares outstanding | 249,914,536 | 227,189,980 |
| Other comprehensive income | Diluted income (loss) per share | 0 | 0 |
| Other comprehensive income | Diluted weighted average number of subordinate voting common shares outstanding | 249,914,536 | 231,795,875 |
| Net income (loss) for the period attributable to: | Shareholders | -2,702,217 | 598,782 |
| Net income (loss) for the period attributable to: | Non-controlling interest | 488,826 | 144,088 |
| Net income (loss) for the period attributable to: | Net income (loss) | -2,213,391 | 742,870 |
| Total comprehensive income (loss) for the period attributable to: | Shareholders | -2,702,217 | 606,614 |
| Total comprehensive income (loss) for the period attributable to: | Non-controlling interest | 488,826 | 144,088 |
| Total comprehensive income (loss) for the period attributable to: | Total comprehensive income (loss) | -2,213,391 | 750,702 |

### Income Statement (Adjusted EBITDA Reconciliation — (US$ in millions))

| | 2026 | 2025 |
|---|---:|---:|
| Net income (loss) | -2,213,391 | 742,870 |
| Add back amortization of property and equipment included in cost of sales | 822,531 | 434,202 |
| Add back interest and interest accretion expense | 549,980 | 258,171 |
| Add back amortization of property and equipment | 91,162 | 104,984 |
| Add back loss on equity investment in associate | 99,657 | 153,734 |
| Add back income tax expense | 516,871 | 631,310 |
| Deduct gain on derivative liability | -66,377 | -2,835,085 |
| Deduct interest expense and other income (expense) | -207,455 | -832,893 |
| Add back changes in FV on warrants asset and liability | 1,420,370 | 1,172,492 |
| EBITDA | 1,013,346 | -170,215 |
| Add back share-based compensation | 154,994 | 1,435,910 |
| Deduct GAAP bad debt conversion adjustment |  | -79,000 |
| Add back pre-operational startup costs ¹ | 396,165 |  |
| Adjusted EBITDA | 1,564,505 | 1,186,695 |

### Income Statement (Consolidated — (US$ in millions))

| | Oregon – $ | Michigan – $ | New Jersey – $ | Corporate – $ | Consolidated – $ |
|---|---:|---:|---:|---:|---:|
| Revenue | 2,996,764 | 2,743,527 | 3,415,368 |  | 9,155,658 |
| Total cost of goods sold | -2,445,600 | -1,418,264 | -1,334,160 |  | -5,198,024 |
| Gross profit | 551,164 | 1,325,262 | 2,081,208 |  | 3,957,634 |
| Operating expenses | General and administration | 445,276 | 995,421 | 867,242 | 1,303,884 | 3,611,823 |
| Operating expenses | Depreciation and amortization | 31,341 | 37,915 | 20,530 | 1,376 | 91,162 |
| Operating expenses | Share based compensation |  |  |  | 154,994 | 154,994 |
| Other income and expense | Interest and accretion | -5,477 | -4,013 | -141,003 | -399,487 | -549,980 |
| Other income and expense | Interest and other income (expense) | 10,000 | 61,664 | -7,610 | 143,401 | 207,455 |
| Other income and expense | Unrealized loss on derivative liability |  |  |  | 66,377 | 66,377 |
| Other income and expense | Unrealized gain (loss) on warrants asset |  |  |  | -2,191,084 | -2,191,084 |
| Other income and expense | Unrealized gain on warrant liability |  |  |  | 770,714 | 770,714 |
| Other income and expense | Loss on equity method investment |  |  |  | -99,657 | -99,657 |
| Other income and expense | Net income (loss) before tax | 79,070 | 349,578 | 1,044,823 | -3,169,990 | -1,696,520 |
| Other income and expense | Tax |  |  |  | -516,871 | -516,871 |
| Other income and expense | Net income (loss) | 79,070 | 349,578 | 1,044,823 | -3,686,861 | -2,213,391 |
| EBITDA Adjustments | Amortization in cost of sales | 320,567 | 207,260 | 294,703 |  | 822,531 |
| EBITDA Adjustments | Amortization of property and equipment | 31,341 | 37,915 | 20,530 | 1,376 | 91,162 |
| EBITDA Adjustments | Interest and accretion | 5,477 | 4,013 | 141,003 | 399,487 | 549,980 |
| EBITDA Adjustments | Interest and other income (expense) | -10,000 | -61,664 | 7,610 | -143,401 | -207,455 |
| EBITDA Adjustments | Change in fair value of derivative liability |  |  |  | -66,377 | -66,377 |
| EBITDA Adjustments | Unrealized warrants asset |  |  |  | 1,420,370 | 1,420,370 |
| EBITDA Adjustments | Loss on equity method investment |  |  |  | 99,657 | 99,657 |

### Income Statement (Adjusted EBITDA Reconciliation — (US$ in millions))

| | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---:|---:|---:|---:|---:|
| Revenue | 9,155,658 | 8,753,498 | 8,514,268 | 8,009,987 | 7,150,183 |
| Total cost of goods sold | -5,198,024 | -5,184,072 | -4,855,244 | -4,455,502 | -3,786,436 |
| Gross profit | 3,957,634 | 3,569,426 | 3,659,024 | 3,554,485 | 3,363,747 |
| Operating expenses | General and administration | 3,611,823 | 3,468,822 | 2,964,469 | 2,678,372 | 2,532,254 |
| Operating expenses | Depreciation and amortization | 91,162 | 378,654 | 110,693 | 107,927 | 104,984 |
| Operating expenses | Share based compensation | 154,994 | 306,308 | 314,951 | 336,825 | 1,435,910 |
| Other income and expenses | Interest and accretion | -549,980 | -283,105 | -410,925 | -432,553 | -258,171 |
| Other income and expenses | Interest and other income (expense) | 207,455 | 260,679 | 156,439 | -137,550 | 832,893 |
| Other income and expenses | Unrealized loss on derivative liability | 66,377 | 96,813 | -24,242 | -2,892,027 | 2,864,373 |
| Other income and expenses | Realized gain on derivative liability | 0 | 0 | 0 | 5,889,032 | -29,288 |
| Other income and expenses | Unrealized gain (loss) on warrants asset | -2,191,084 | -573,956 | 2,162,087 | -168,162 | -1,172,492 |
| Other income and expenses | Unrealized gain on warrant liability | 770,714 | 0 | 0 | 0 | 0 |
| Other income and expenses | Loss on equity method investment | -99,657 | -108,809 | -75,733 | -114,686 | -153,734 |
| Other income and expenses | Net income (loss) before tax | -1,696,520 | -1,192,736 | 2,076,537 | 2,575,415 | 1,374,180 |
| Other income and expenses | Tax | -516,871 | 459,289 | -511,381 | -920,037 | -631,310 |
| Other income and expenses | Net income (loss) | -2,213,391 | -733,447 | 1,565,156 | 1,655,378 | 742,870 |
| EBITDA adjustments | Amortization in cost of sales | 822,531 | 702,751 | 895,472 | 658,232 | 434,202 |
| EBITDA adjustments | Amortization of property and equipment | 91,162 | 378,654 | 110,693 | 107,927 | 104,984 |
| EBITDA adjustments | Interest and accretion | 549,980 | 283,105 | 410,925 | 432,553 | 258,171 |
| EBITDA adjustments | Interest and other income (expense) | -207,455 | -260,679 | -156,439 | 137,550 | -832,893 |
| EBITDA adjustments | Change in fair value of derivative liability | -66,377 | -96,813 | 24,242 | -2,997,005 | -2,835,085 |
| EBITDA adjustments | Unrealized warrants asset | 1,420,370 | 573,956 | -2,162,087 | 168,162 | 1,172,492 |
| EBITDA adjustments | Loss on equity method investment | 99,657 | 108,809 | 75,733 | 114,686 | 153,734 |
| EBITDA adjustments | Income tax | 516,871 | -459,289 | 511,381 | 920,037 | 631,310 |
| EBITDA adjustments | EBITDA before one-time adjustments | 1,013,346 | 497,047 | 1,275,076 | 1,197,520 | -170,215 |
| EBITDA adjustments | Share-based compensation | 154,994 | 306,308 | 314,951 | 336,825 | 1,435,910 |
| EBITDA adjustments | Golden Harvests acquisition costs | 0 | 60,000 | 0 | 60,000 | 0 |
| EBITDA adjustments | GAAP conversion bad debt adjustment | 0 | 237,000 | -79,000 | -79,000 | -79,000 |
| EBITDA adjustments | Pre-operational startup costs | 396,165 | 72,217 | 0 | 0 | 0 |
| EBITDA adjustments | Adjusted EBITDA | 1,564,505 | 1,172,572 | 1,511,027 | 1,515,345 | 1,186,695 |

### Balance Sheet (March 31, 2026 — (US$ in millions))

| | March 31, 2026 – $ | December 31, 2025 – $ |
|---|---:|---:|
| Current assets | Cash and cash equivalents | 13,701,247 | 11,371,834 |
| Current assets | Accounts receivable, net (Note 4) | 3,239,626 | 2,908,270 |
| Current assets | Inventory (Note 5) | 7,138,400 | 7,081,295 |
| Current assets | Prepaid expenses | 516,553 | 563,912 |
| Current assets | Current portion of notes receivable | 259,653 | 253,403 |
| Current assets | Total current assets | 24,855,479 | 22,178,714 |
| Current assets | Other long-term assets | 300,000 | 300,000 |
| Current assets | Warrants asset (Note 6) | 2,912,188 | 5,103,272 |
| Current assets | Other Investments (Note 7) | 1,459,203 | 1,358,860 |
| Current assets | Notes receivable (Note 8) | 1,719,694 | 1,683,757 |
| Current assets | Lease receivable | 94,022 | 94,022 |
| Current assets | Property and equipment, net (Note 9) | 15,467,088 | 14,055,552 |
| Current assets | Right of use assets (Note 10) | 14,065,295 | 13,414,406 |
| Current assets | Deferred tax asset | 1,944,078 | 1,522,760 |
| Current assets | Intangible assets | 3,025,193 | 3,025,193 |
| Current assets | TOTAL ASSETS | 65,842,240 | 62,736,536 |
| Current liabilities | Accounts payable and accrued liabilities | 2,731,607 | 1,262,519 |
| Current liabilities | Current portion of operating lease liabilities | 965,115 | 844,421 |
| Current liabilities | Current portion of finance lease liabilities | 158,477 | 152,705 |
| Current liabilities | Current portion of long-term debt | 2,765,900 | 2,576,228 |
| Current liabilities | Current portion of business acquisition consideration payable (Note 20) | 553,064 | 455,844 |
| Current liabilities | Derivative liability | 70,664 | 137,041 |
| Current liabilities | Warrant liabilities (Note 13.3) | 768,951 |  |
| Current liabilities | Income tax payable | 286,980 | 296,018 |
| Current liabilities | Total current liabilities | 8,300,758 | 5,724,776 |
| Current liabilities | Operating lease liabilities | 13,618,798 | 13,010,805 |
| Current liabilities | Finance lease liabilities | 51,359 | 67,782 |
| Current liabilities | Long-term debt | 9,916,224 | 10,019,301 |
| Current liabilities | Business acquisition consideration payable (Note 20) | 1,485,820 | 1,611,637 |
| Current liabilities | Other non-current liabilities | 9,227,313 | 8,383,888 |
| Current liabilities | Total liabilities | 42,600,272 | 38,818,189 |

### Cash Flow ((US$ in millions))

| | 2026 – $ | 2025 – $ |
|---|---:|---:|
| Operating activities | Net income (loss) | -2,213,391 | 742,870 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Depreciation of property and equipment | 91,162 | 104,984 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Depreciation of property and equipment included in costs of finished cannabis inventory sold | 822,531 | 315,216 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Lease costs included in costs of finished cannabis inventory sold | 199,415 | 34,055 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Share-based compensation | 154,994 | 1,435,910 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Interest and accretion expense | 549,980 | 258,171 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Other income |  | -41,501 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Interest income | -42,187 | -35,937 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Unrealized (gain) loss on derivative liability | -66,377 | -2,864,373 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Realized (gain) loss on derivative liability |  | 29,288 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Unrealized loss on warrant asset | 2,191,084 | 1,172,492 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Unrealized gain on warrant liability | -770,714 |  |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Loss on equity investment in associate | 99,657 | 153,734 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Deferred income taxes | -421,318 | -63,418 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Changes in operating assets and liabilities (Note 19) | 1,939,688 | -2,246,071 |
| Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification: | Net cash provided by (used in) operating activities | 2,534,524 | -1,004,580 |
| Investing activities | Purchase of property and equipment | -2,517,414 | -241,532 |
| Investing activities | Payments of business acquisition consideration payable | -157,199 | -43,290 |
| Investing activities | Investment in Rogue EBC, LLC equity interest | -200,000 | -49,000 |
| Investing activities | Net cash used in investing activities | -2,874,613 | -333,822 |
| Financing activities | Sale of non-controlling interest in GRMA, net of issuance costs | 2,985,000 |  |
| Financing activities | Proceeds from exercise of stock options | 21,839 | 16,038 |
| Financing activities | Proceeds from long-term debt | 500,000 | 7,250,155 |
| Financing activities | Distributions to non-controlling interests in subsidiaries | -85,156 |  |
| Financing activities | Debt issuance costs |  | -213,373 |
| Financing activities | Repayment of long-term debt | -733,431 | -732,004 |
| Financing activities | Payment of interest on convertible debentures |  | -75,529 |
| Financing activities | Repayment of finance lease | -18,750 |  |
| Financing activities | Net cash provided by financing activities | 2,669,502 | 6,245,287 |
| Financing activities | Effect of foreign exchange on cash and cash equivalents |  | 7,832 |
| Financing activities | Change in cash and cash equivalents | 2,329,413 | 4,906,885 |
| Financing activities | Cash and cash equivalents, beginning of period | 11,371,834 | 4,917,708 |
| Financing activities | Cash and cash equivalents, ending of period | 13,701,247 | 9,832,425 |
